Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Paola Mattiolo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5601-0879; OpenAlex author ID A5033577986. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
52
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 11

  1. High fidelity of Claudin-18.2 expression in primary and matched metastatic (lymph nodes, peritoneum, and liver) pancreatic ductal adenocarcinoma: a foundation … Co-author DOI 10.1016/j.humpath.2025.106014↗
  2. Morphologic Characterization of Pancreatic Ductal Adenocarcinoma following Post-neoadjuvant Pancreatectomy and Clinical Value of Intratumor Heterogeneity. First author DOI 10.1097/sla.0000000000006565↗
  3. Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characte… Co-author DOI 10.1002/path.6437↗
  4. Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-institution… Co-author DOI 10.1097/sla.0000000000006322↗
  5. Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy. Co-author DOI 10.1093/bjs/znad146↗
  6. CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal… Co-author DOI 10.1245/s10434-022-12622-w↗
  7. Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metas… Co-author DOI 10.1007/s00428-021-03205-3↗
  8. Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic. Co-author DOI 10.1080/14728222.2022.2021397↗
  9. Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions. First author DOI 10.3390/cancers13133119↗
  10. KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities. Co-author DOI 10.1186/s13046-020-01732-6↗
  11. Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology. Co-author DOI 10.3390/ijms21228841↗

Closest collaborators

The 25 strongest of 52 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudio Luchini · 11 shared papers, 2020–2026 · strength 1.75
  2. Aldo Scarpa · 11 shared papers, 2020–2026 · strength 1.75
  3. Giuseppe Malleo · 9 shared papers, 2020–2026 · strength 1.48
  4. Roberto Salvia · 9 shared papers, 2020–2026 · strength 1.48
  5. Rita Teresa Lawlor · 6 shared papers, 2020–2026 · strength 0.90
  6. Gabriella Lionetto · 4 shared papers, 2023–2026 · strength 0.74
  7. Carlotta Franzina · 3 shared papers, 2025–2026 · strength 0.66
  8. Antonio Pea · 4 shared papers, 2021–2026 · strength 0.63
  9. Michèle Milella · 5 shared papers, 2020–2022 · strength 0.58
  10. Andrea Mafficini · 4 shared papers, 2021–2025 · strength 0.55
  11. Lodewijk A.A. Brosens · 4 shared papers, 2021–2025 · strength 0.55
  12. Matteo Fassan · 2 shared papers, 2026 · strength 0.50
  13. Giulio Belfiori · 3 shared papers, 2023–2025 · strength 0.50
  14. Massimo Falconi · 3 shared papers, 2023–2025 · strength 0.50
  15. Stefano Crippa · 3 shared papers, 2023–2025 · strength 0.50
  16. Fabio Casciani · 2 shared papers, 2025–2026 · strength 0.44
  17. Alessandro Esposito · 2 shared papers, 2025–2026 · strength 0.44
  18. Salvatore Paiella · 2 shared papers, 2025–2026 · strength 0.44
  19. Carlos Fernández-del Castillo · 2 shared papers, 2023–2025 · strength 0.34
  20. Cristina Rosa Ferrone · 2 shared papers, 2023–2025 · strength 0.34
  21. Vincenzo Corbo · 2 shared papers, 2022–2025 · strength 0.32
  22. Claudio Doglioni · 2 shared papers, 2023 · strength 0.30
  23. Laura Maggino · 2 shared papers, 2023 · strength 0.30
  24. Giulia Gasparini · 2 shared papers, 2023 · strength 0.30
  25. Claudio Bassi · 2 shared papers, 2023 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.